Sattar Rabia, Ali S Abid, Abbasi Atiya
International Center for Chemical Sciences, HEJ Research Institute of Chemistry, University of Karachi, Karachi 75270, Pakistan.
Biochem Biophys Res Commun. 2003 Sep 5;308(4):726-35. doi: 10.1016/s0006-291x(03)01458-x.
Cytotoxic lymphocytes (CTLs), the key players of cell mediated immunity, induce apoptosis by engaging death receptors or through exocytosis of cytolytic granules containing granzyme (proteases) and pore-forming protein (perforin). The crystal structure of granzyme B from human (B(h)) and rat (B(r)), as well as that of pro-granzyme K (K(h)) has been reported recently. In the present communication, we describe the homology modeling of granzyme family (in particular Gzm A(h), M(h), B(m), and C(m) from human and mouse) based on the crystal structural coordinates of trypsin, granzyme K (K(h)), and granzyme B (B(h)). These models have been used for establishing phylogenetic relationship as well as identifying characteristic features for designing specific inhibitors. The paper also highlights key residues at the S1, S2, and S2(') binding subsites in all granzyme, which may be involved in the structure-function relationship of this enzyme family. The predicted 3D homology models show a conserved two similar domain structure, i.e., an N-terminal domain and a C-terminal domain comprising predominantly of beta-sheet structure with a little alpha-helical content. Micro-heterogeneities have been observed in the vicinity of the active site in all granzymes as compared to granzyme B(h). For example, in granzyme M(h), valine is present at the S1 subsite instead of arginine. Similarly differences at S2 (Leu-->Phe), S3 (Ser-->Gly), and S4 (Arg-->Asn) subsites are quite apparent and appear to hold the potential for selective designing of inhibitors for possible therapeutic applications. Furthermore, analysis of the electrostatic surface potential on the shape of granzyme-inhibitor binding groove reveals clear differences at the reactive site. Additionally the different posttranslational modification sites such as phosphorylation (e.g., in granzyme M Thr101, Ser109), myristoylation (Gly22, 117, and 131), and glycosylation (Ser160) have been identified, as very little is known about the functional significance of these modifications in the granzyme family. Thus, glycosylation at Ser160 in granzyme M may influence the net charge of the enzyme, resulting in altered substrate binding as compared to granzyme B. Also this modification may influence the rate of complexation and binding affinity with proteoglycans. These studies are expected to contribute towards the basic understanding of functional associations of the granzymes with other molecules and their possible role in apoptosis.
细胞毒性淋巴细胞(CTLs)是细胞介导免疫的关键参与者,通过激活死亡受体或通过胞吐含有颗粒酶(蛋白酶)和穿孔素(成孔蛋白)的溶细胞颗粒来诱导细胞凋亡。最近已经报道了人源(B(h))和大鼠源(B(r))颗粒酶B以及前颗粒酶K(K(h))的晶体结构。在本通讯中,我们基于胰蛋白酶、颗粒酶K(K(h))和颗粒酶B(B(h))的晶体结构坐标描述了颗粒酶家族(特别是来自人和小鼠的Gzm A(h)、M(h)、B(m)和C(m))的同源建模。这些模型已被用于建立系统发育关系以及识别设计特异性抑制剂的特征。本文还突出了所有颗粒酶在S1、S2和S2(')结合亚位点的关键残基,这些残基可能参与该酶家族的结构-功能关系。预测的三维同源模型显示出保守的两个相似结构域结构,即一个N端结构域和一个C端结构域,主要由β-折叠结构组成,含有少量α-螺旋成分。与颗粒酶B(h)相比,在所有颗粒酶的活性位点附近都观察到了微异质性。例如,在颗粒酶M(h)中,S1亚位点存在缬氨酸而非精氨酸。类似地,S2(亮氨酸→苯丙氨酸)、S3(丝氨酸→甘氨酸)和S4(精氨酸→天冬酰胺)亚位点的差异也很明显,似乎具有为可能的治疗应用选择性设计抑制剂的潜力。此外,对颗粒酶-抑制剂结合凹槽形状上的静电表面电位分析揭示了反应位点的明显差异。此外,还确定了不同的翻译后修饰位点,如磷酸化(例如颗粒酶M中的苏氨酸101、丝氨酸109)、肉豆蔻酰化(甘氨酸22、117和131)和糖基化(丝氨酸160),因为对颗粒酶家族中这些修饰的功能意义了解甚少。因此,颗粒酶M中丝氨酸160处的糖基化可能会影响酶的净电荷,与颗粒酶B相比导致底物结合改变。而且这种修饰可能会影响与蛋白聚糖的络合速率和结合亲和力。这些研究有望有助于对颗粒酶与其他分子的功能关联及其在细胞凋亡中可能作用的基本理解。